Ectonucleotidase modulation of age-dependent vascular calcification and stiffness
外切核苷酸酶调节年龄依赖性血管钙化和僵硬度
基本信息
- 批准号:10045790
- 负责人:
- 金额:$ 24.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Abstract
With increasing age, blood vessels become stiffer and more calcified. In the latter years of the human lifespan,
the process of vascular aging accelerates. The reason that blood vessels lose their youthful elasticity and
ability to retard the deposition of calcium precipitously later in life is poorly understood. Ectonucleotidases are
found on the surface of endothelial cells which line the inner surface of blood vessels, vascular smooth muscle
cells, and leukocytes. The ectonucleotidase CD39 is responsible for cleaving ATP and ADP to form AMP, and
subsequently, CD73 is responsible for generating adenosine from AMP. Since ATP and ADP are pro-
inflammatory and act in a paracrine fashion, I hypothesize that ectonucleotidase activity plays a role in the
vascular stiffness and calcification that occurs as a consequence of age. This is supported by my preliminary
data in wild type (C57BL/6) mice, which demonstrates CD73 protein levels declined with age (up to 24 months)
in the heart and kidney. This is also supported by preliminary data in mice and human tissues demonstrating
that loss of CD73 expression promoted expression of the transcription factor Runx2, which is critical for
osteogenesis. We hypothesize that loss of ectonucleotidase expression with age could have deleterious
consequences on the vessel wall, resulting in an environment which promotes vascular calcification and
stiffness. Since the role of ectonucleotidases in vascular aging is unknown, we will elucidate mechanisms
which mediate age-dependent vascular calcification through the following aims. Aim 1: We will determine how
age-dependent decline in vascular ectonucleotidase expression renders vessels susceptible to vascular
calcification and fibrosis in a murine model. Aim 2: We will determine how ectonucleotidase activity mitigates
arterial fibrosis and stiffness. Aim 3: We will determine if ectonucleotidase expression plays a role in age-driven
human coronary artery calcification. Achievement of these aims will elucidate the role of ectonucleotidases in
age-dependent vascular calcification and stiffness in mice and humans. The mechanistic insights obtained
from these experiments will define my future investigative direction and serve as a foundation for a subsequent
RO1 application as an independent investigator studying vascular biology and aging.
抽象的
随着年龄的增长,血管变得更硬,更钙化。在人类寿命的后期,
血管衰老的过程加速。血管失去年轻弹性的原因和
人们对钙的沉积能力降低了以后生命的后期沉积的能力。核苷酸酶是
在血管内部表面,血管平滑肌的内表面上发现
细胞和白细胞。 Ectonucleotidase CD39负责分裂ATP和ADP形成AMP,并且
随后,CD73负责从AMP产生腺苷。由于ATP和ADP是Pro-
我假设炎症性和作用于旁分泌方式,肾上腺素酶的活性在
由于年龄而发生的血管僵硬和钙化。这是我的初步支持的
野生型(C57BL/6)小鼠的数据显示CD73蛋白水平随着年龄的增长而下降(长达24个月)
在心脏和肾脏中。这也得到了小鼠和人体组织的初步数据的支持
CD73表达的损失促进了转录因子Runx2的表达,这对于
成骨。我们假设随着年龄的年龄而失去核苷酸酶表达的丧失可能会有有害
容器壁的后果,导致促进血管钙化和
刚性。由于邻核酶在血管衰老中的作用尚不清楚,因此我们将阐明机制
通过以下目的介导年龄依赖年龄的血管钙化。目标1:我们将确定如何
血管外核苷酸酶表达的年龄依赖性下降使血管易于血管
鼠模型中的钙化和纤维化。 AIM 2:我们将确定邻核酶的活性如何减轻
动脉纤维化和僵硬。 AIM 3:我们将确定邻核核苷酸酶表达是否在年龄驱动中起作用
人冠状动脉钙化。这些目标的实现将阐明过核苷酸酶在
小鼠和人类的年龄依赖性血管钙化和刚度。获得的机械见解
从这些实验中,将定义我未来的调查方向,并成为随后的基础
RO1应用是研究血管生物学和衰老的独立研究者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Nadia Razaq Sutton其他文献
THE CURRENT CULTURE OF INTERVENTIONAL CARDIOLOGY: PROGRESSIVELY CHANGING OR STATUS QUO?
- DOI:10.1016/s0735-1097(22)01600-x10.1016/s0735-1097(22)01600-x
- 发表时间:2022-03-082022-03-08
- 期刊:
- 影响因子:
- 作者:Zarina Sharalaya;Quinn Capers;Ki Park;Nadia Razaq Sutton;Toniya Singh;Sarah Gualano;Joanna Ghobrial;Kyoko Miki;Anne Rzeszut;Claire S. DuvernoyZarina Sharalaya;Quinn Capers;Ki Park;Nadia Razaq Sutton;Toniya Singh;Sarah Gualano;Joanna Ghobrial;Kyoko Miki;Anne Rzeszut;Claire S. Duvernoy
- 通讯作者:Claire S. DuvernoyClaire S. Duvernoy
共 1 条
- 1
Nadia Razaq Sutton的其他基金
Ectonucleotidase modulation of age-dependent vascular calcification and stiffness
外切核苷酸酶调节年龄依赖性血管钙化和僵硬度
- 批准号:1043403810434038
- 财政年份:2020
- 资助金额:$ 24.3万$ 24.3万
- 项目类别:
Ectonucleotidase modulation of age-dependent vascular calcification and stiffness
外切核苷酸酶调节年龄依赖性血管钙化和僵硬度
- 批准号:1075482510754825
- 财政年份:2020
- 资助金额:$ 24.3万$ 24.3万
- 项目类别:
Ectonucleotidase modulation of age-dependent vascular calcification and stiffness
外切核苷酸酶调节年龄依赖性血管钙化和僵硬度
- 批准号:1022702510227025
- 财政年份:2020
- 资助金额:$ 24.3万$ 24.3万
- 项目类别:
相似国自然基金
甲状腺激素核受体α1突变通过抑制 Atp2b2 基因转录参与Tau蛋白过度磷酸化的分子机制研究
- 批准号:82270831
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
甲状腺激素核受体α1突变通过抑制 Atp2b2 基因转录参与Tau蛋白过度磷酸化的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
Müller细胞CD40/CD154共刺激信号通路对ATP-P2X7受体调节青光眼性视神经病变的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Müller细胞CD40/CD154共刺激信号通路对ATP-P2X7受体调节青光眼性视神经病变的作用及机制研究
- 批准号:82101121
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
研究高血压早期ATP-P2X7受体通路被激活的分子机制及其影响
- 批准号:31970898
- 批准年份:2019
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
Ectonucleotidase modulation of age-dependent vascular calcification and stiffness
外切核苷酸酶调节年龄依赖性血管钙化和僵硬度
- 批准号:1043403810434038
- 财政年份:2020
- 资助金额:$ 24.3万$ 24.3万
- 项目类别:
Ectonucleotidase modulation of age-dependent vascular calcification and stiffness
外切核苷酸酶调节年龄依赖性血管钙化和僵硬度
- 批准号:1075482510754825
- 财政年份:2020
- 资助金额:$ 24.3万$ 24.3万
- 项目类别:
Ectonucleotidase modulation of age-dependent vascular calcification and stiffness
外切核苷酸酶调节年龄依赖性血管钙化和僵硬度
- 批准号:1022702510227025
- 财政年份:2020
- 资助金额:$ 24.3万$ 24.3万
- 项目类别:
Improving Rate/Quality Limitations in Membrane Protein Structure Determination
改善膜蛋白结构测定中的速率/质量限制
- 批准号:77151177715117
- 财政年份:2009
- 资助金额:$ 24.3万$ 24.3万
- 项目类别:
Structure and Regulation of hsp90 Chaperones
hsp90 分子伴侣的结构和调控
- 批准号:72287967228796
- 财政年份:2005
- 资助金额:$ 24.3万$ 24.3万
- 项目类别: